Webinars and Sponsored Roundtables — Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.

Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice

Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Marketplace Directory

Alkaline-phosphatase polymer reagents, 4/13:86

Vector Laboratories now offers its ImmPress polymer detection reagents with alkaline phosphatase as the enzyme detection system. Available as anti-mouse and anti-rabbit ImmPress-AP alkaline-phosphatase polymer reagents, these products are designed to detect primary antibodies made in rabbit and mouse in immunohistochemical staining. They provide greater sensitivity than conventional alkaline-phosphatase antibody conjugates and other alkaline-phosphatase detection reagents.

Improved adenovirus detection for panel, 4/13:85

BioFire Diagnostics has received FDA clearance for its updated Film-Array respiratory panel. The purpose of the updated panel is to improve the detection of adenovirus. Studies performed to support the clearance of the modified panel demonstrated a 73 percent increase in the detection of adenovirus and a threefold improvement in the limit of detection when compared with the original panel.

Online digital pathology network, 4/13:85

PathCentral’s Pathology Network, www.pathcentralpro.net, is a comprehensive online information exchange and digital consultation forum. The network allows physicians to upload case files using digital images for pathologists to review and render critical consulting diagnoses on a global and a domestic real-time basis. The network seeks to connect pathologists by incorporating social media tools, making the forum ideal for pathologists to send and perform consultations, post information, share cases, ask questions, and expand professional relationships.

Whole-slide imaging application for AP QA, 4/13:85

QualityStar will present at the Cambridge Healthtech Institute’s Ninth Annual Biomarkers and Diagnostics World Congress a new application that uses whole-slide digital imaging (WSI) for anatomic pathology external peer review quality assurance. The presentation will review current quality assurance programs and the application of WSI as an approach to gain longitudinal benchmarking data for quality review.

RSV and hMPV assay, 4/13:85

Quidel has received FDA 510(k) clearance for its Molecular RSV and hMPV assay for the detection of respiratory syncytial virus and human metapneumovirus. The assay distinguishes between RSV and hMPV. The RSV and hMPV assay can be batched alongside other Quidel Molecular assays, such as the influenza A and B PCR assay, in the same multiwell panel for customized multiplexing capability.

Exome kits, software for next-gen sequencing, 4/13:84

Agilent Technologies’ HaloPlex exome kits and SureCall software complement the company’s Web-based SureDesign interface and custom HaloPlex gene panels to provide a complete, integrated workflow. The HaloPlex exome kit comprises about 2.5 million probes to provide comprehensive coverage of the coding regions of the human genome with minimal hands-on time. The kit requires only 200 ng of input DNA.

ACD, Hopkins reach cancer biomarkers deal, 4/13:84

Advanced Cell Diagnostics has entered into an agreement with Johns Hopkins University on behalf of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, whereby ACD’s RNAscope technology will be used to validate novel biomarkers and drug targets for cancer immunotherapy.

Staining platform, 4/13:84

Dako’s Omnis solution, a new addition to the company’s immunohistochemistry portfolio, consists of hardware, software, and reagents. It automates IHC and ISH processes, allowing entire patient cases to be processed simultaneously. The solution offers continuous loading, batch loading, and overnight run options. Its state-of-the-art software allows slide processing and instrument maintenance to be traced to individual operators, greatly increasing quality control.

CRC detection test, 3/13:75

Epigenomics has submitted to the FDA the fourth and final module of its premarket approval for its blood-based Epi proColon test for the detection of colorectal cancer.

In vivo imaging system, 3/13:76

PerkinElmer’s Ivis Lumina series III benchtop platform is for oncology, infectious disease, and drug discovery and efficacy research. The system integrates bioluminescence and full spectral fluorescence in vivo imaging technologies, providing an expandable and sensitive benchtop imaging platform.